Recent Finacing
Recent Raise
Neuroplast develops Neuro-Cells®, an autologous therapy from patients' bone marrow‑derived hematopoietic and mesenchymal stem cells for acute traumatic spinal cord injury, with GMP manufacturing and European Orphan designation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
